Standard (8 weeks) vs long (12 weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR)

BACKGROUND: The optimal timing of surgery in relation to chemoradiation is still controversial. Retrospective analysis has demonstrated in the recent decades that the regression of adenocarcinoma can be slow and not complete until after several months. More recently, increasing pathologic Complete R...

Descripción completa

Detalles Bibliográficos
Autores principales: Monsellato, Igor, Alongi, Filippo, Bertocchi, Elisa, Gori, Stefania, Ruffo, Giacomo, Cassinotti, Elisa, Baldarti, Ludovica, Boni, Luigi, Pernazza, Graziano, Pulighe, Fabio, De Nisco, Carlo, Perinotti, Roberto, Morpurgo, Emilio, Contardo, Tania, Mammano, Enzo, Elmore, Ugo, Delpini, Roberto, Rosati, Riccardo, Perna, Federico, Coratti, Andrea, Menegatti, Benedetta, Gentilli, Sergio, Baroffio, Paolo, Buccianti, Piero, Balestri, Riccardo, Ceccarelli, Cristina, Torri, Valter, Cavaliere, Davide, Solaini, Leonardo, Ercolani, Giorgio, Traverso, Elena, Fusco, Vittorio, Rossi, Maura, Priora, Fabio, Numico, G., Franzone, Paola, Orecchia, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912945/
https://www.ncbi.nlm.nih.gov/pubmed/31842784
http://dx.doi.org/10.1186/s12885-019-6271-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912945/
https://www.ncbi.nlm.nih.gov/pubmed/31842784
http://dx.doi.org/10.1186/s12885-019-6271-3

Ejemplares similares